Lecanemab Mark a Turning Point in Alzheimer’s Treatment
The FDA has approved a new Alzheimer’s Disease therapy - Lecanemab. Find out more in this Formaspace Laboratory report. AUSTIN, TEXAS, UNITED STATES, April 19, 2023 /EINPresswire.com/ -- Optimism Prevailed At The 2022 Clinical Trials On Alzheimer’s …